Mivision

Combining clinical treatment with a home care routine creates a comprehensive approach to managing dry eye over the long term. Rae De Zilva from Optopol explains how the versatile Thermaeye Plus device, which features fractional pulse technology, sapphire cooling and fingertip filters, targets periocular treatment in the clinic. She also introduces the Weye home-care range, and explains how the two approaches complement each other to support ocular surface health.

Developed specifically for anglers and the environments they fish, the collaboration combines the expertise of two brands with long histories of technical innovation – Shimano in fishing tackle and Revo in performance optics. For more than 100 years, Shimano has built a global reputation for precision engineering across fishing and cycling.

A simple, visual way to explain refractive error to patients, showing how myopia, hyperopia, and astigmatism affect vision and why correction is needed.

Idra X detects the eye and performs a comprehensive series of assessments of the ocular surface and dry eye, following guided protocols that ensure optimal data acquisition. It details the patient’s condition, including dry eye type, severity, and classification, supporting the choice of targeted and effective treatment. This automatic functionality improves the precision, reliability and repeatability of ocular surface and dry eye measurements between sessions and across operator experience.

This is the 10th Indigenous artist collaboration for Specsavers, with AU$25 from each frame sold supporting the work of The Fred Hollows Foundation’s Indigenous Australia Program. At the heart of this year’s collection is the artwork Tjukurpa Mulayangu, which is deeply rooted in Ms Intjalki’s connection to Country. Her vibrant design portrays her father’s Country, featuring tjanpi (native grass) and numerous tjukula (waterholes).

Ocular allergy is one of the most common presentations in primary eye care, yet it remains one of the most underestimated. Surveys suggest that up to 20% of the world’s population is affected by some form of allergic conjunctivitis, with prevalence continuing to rise, particularly in urbanised settings.1 In Australia, where both the pollen calendar and the dust mite burden are considerable, the allergic eye is a year-round clinical reality.

Increasing numbers of Australians are being prescribed GLP-1 receptor agonists (GLP-1 RAs). These medications – semaglutide (Ozempic, Wegovy), liraglutide (Saxenda), tirzepatide (Mounjaro), and dulaglutide (Trulicity) – have transformed the management of type 2 diabetes and obesity.

Yuvezzi received approval from the US Food and Drug Administration (FDA) in January this year as the first and only dual-agent (combination) eye drop approved for the treatment of presbyopia in adults.

Sustainability is about meeting today’s needs without compromising the ability of future generations to meet their own needs by balancing environmental protection, social wellbeing, and economic prosperity. The health industry, as a whole, has a large impact on the environment.

Queensland has long been known as “the land of refractive lens exchange” – a market dominated by intraocular lens procedures rather than laser correction. So when I invested in the complete ZEISS refractive platform 12 months ago – Presbyond – for the correction of presbyopia, and SMILEPro for near/far sightedness and astigmatism – colleagues might reasonably have raised an eyebrow.